Literature DB >> 29018128

Island Sign: An Imaging Predictor for Early Hematoma Expansion and Poor Outcome in Patients With Intracerebral Hemorrhage.

Qi Li1, Qing-Jun Liu2, Wen-Song Yang2, Xing-Chen Wang2, Li-Bo Zhao2, Xin Xiong2, Rui Li2, Du Cao2, Dan Zhu2, Xiao Wei2, Peng Xie2.   

Abstract

BACKGROUND AND
PURPOSE: The aim of the study was to investigate the usefulness of the computed tomography (CT) island sign for predicting early hematoma growth and poor functional outcome.
METHODS: We included patients with spontaneous intracerebral hemorrhage (ICH) who had undergone baseline CT within 6 hours after ICH symptom onset in our hospital between July 2011 and September 2016. Two readers independently assessed the presence of the island sign on the admission noncontrast CT scan. Multivariable logistic regression analysis was used to analyze the association between the presence of the island sign on noncontrast admission CT and early hematoma growth and functional outcome.
RESULTS: A total of 252 patients who met the inclusion criteria were analyzed. Among them, 41 (16.3%) patients had the island sign on baseline noncontrast CT scans. In addition, the island sign was observed in 38 of 85 patients (44.7%) with hematoma growth. Multivariate logistic regression analysis demonstrated that the time to baseline CT scan, initial hematoma volume, and the presence of the island sign on baseline CT scan independently predicted early hematoma growth. The sensitivity of the island sign for predicting hematoma expansion was 44.7%, specificity 98.2%, positive predictive value 92.7%, and negative predictive value 77.7%. After adjusting for the patients' age, baseline Glasgow Coma Scale score, presence of intraventricular hemorrhage, presence of subarachnoid hemorrhage, admission systolic blood pressure, baseline ICH volume, and infratentorial location, the presence of the island sign (odds ratio, 3.51; 95% confidence interval, 1.26-9.81; P=0.017) remained an independent predictor of poor outcome in patients with ICH.
CONCLUSIONS: The island sign is a reliable CT imaging marker that independently predicts hematoma expansion and poor outcome in patients with ICH. The noncontrast CT island sign may serve as a potential marker for therapeutic intervention.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  computed tomography; hematoma growth; intracerebral hemorrhage; predictors; stroke

Mesh:

Substances:

Year:  2017        PMID: 29018128     DOI: 10.1161/STROKEAHA.117.017985

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  44 in total

Review 1.  Computed Tomography Imaging Predictors of Intracerebral Hemorrhage Expansion.

Authors:  Xin-Ni Lv; Lan Deng; Wen-Song Yang; Xiao Wei; Qi Li
Journal:  Curr Neurol Neurosci Rep       Date:  2021-03-12       Impact factor: 5.081

2.  Comparison of CT black hole sign and other CT features in predicting hematoma expansion in patients with ICH.

Authors:  Gui-Nv He; Hao-Zhan Guo; Xiong Han; En-Feng Wang; Yan-Qiu Zhang
Journal:  J Neurol       Date:  2018-06-15       Impact factor: 4.849

Review 3.  Advances in computed tomography-based prognostic methods for intracerebral hemorrhage.

Authors:  Xiaoyu Huang; Dan Wang; Shenglin Li; Qing Zhou; Junlin Zhou
Journal:  Neurosurg Rev       Date:  2022-02-28       Impact factor: 3.042

4.  Initial investigation of predicting hematoma expansion for intracerebral hemorrhage using imaging biomarkers and machine learning.

Authors:  Dennis Swetz; Samantha E Seymour; Ryan A Rava; Mohammad Mahdi Shiraz Bhurwani; Andre Monteiro; Ammad A Baig; Muhammad Waqas; Kenneth V Snyder; Elad I Levy; Jason M Davies; Adnan H Siddiqui; Ciprian N Ionita
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2022-04-04

5.  Development and Validation of a Clinical-Based Signature to Predict the 90-Day Functional Outcome for Spontaneous Intracerebral Hemorrhage.

Authors:  Xiaoyu Huang; Dan Wang; Qiaoying Zhang; Yaqiong Ma; Shenglin Li; Hui Zhao; Juan Deng; Jingjing Yang; JiaLiang Ren; Min Xu; Huaze Xi; Fukai Li; Hongyu Zhang; Yijing Xie; Long Yuan; Yucheng Hai; Mengying Yue; Qing Zhou; Junlin Zhou
Journal:  Front Aging Neurosci       Date:  2022-05-09       Impact factor: 5.702

6.  Noncontrast computer tomography-based radiomics model for predicting intracerebral hemorrhage expansion: preliminary findings and comparison with conventional radiological model.

Authors:  Huihui Xie; Shuai Ma; Xiaoying Wang; Xiaodong Zhang
Journal:  Eur Radiol       Date:  2019-08-05       Impact factor: 5.315

7.  Expansion-Prone Hematoma: Defining a Population at High Risk of Hematoma Growth and Poor Outcome.

Authors:  Qi Li; Yi-Qing Shen; Xiong-Fei Xie; Meng-Zhou Xue; Du Cao; Wen-Song Yang; Rui Li; Lan Deng; Miao Wei; Fa-Jin Lv; Guo-Feng Wu; Zhou-Ping Tang; Peng Xie
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

8.  The new Hematoma Maturity Score is highly associated with poor clinical outcome in spontaneous intracerebral hemorrhage.

Authors:  Elena Serrano; Antonio López-Rueda; Javier Moreno; Alejandro Rodríguez; Laura Llull; Christian Zwanzger; Laura Oleaga; Sergi Amaro
Journal:  Eur Radiol       Date:  2021-06-20       Impact factor: 5.315

9.  Hematoma Expansion in Intracerebral Hemorrhage With Unclear Onset.

Authors:  Andrea Morotti; Gregoire Boulouis; Andreas Charidimou; Qi Li; Loris Poli; Paolo Costa; Valeria De Giuli; Eleonora Leuci; Federico Mazzacane; Giorgio Busto; Francesco Arba; Laura Brancaleoni; Sebastiano Giacomozzi; Luigi Simonetti; Michele Laudisi; Giuseppe Micieli; Anna Cavallini; Elisa Candeloro; Massimo Gamba; Mauro Magoni; Andrew D Warren; Christopher D Anderson; M Edip Gurol; Alessandro Biffi; Anand Viswanathan; Ilaria Casetta; Enrico Fainardi; Andrea Zini; Alessandro Pezzini; Alessandro Padovani; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein
Journal:  Neurology       Date:  2021-04-01       Impact factor: 9.910

10.  Risk Factors for Postoperative Rebleeding and Short-Term Prognosis of Spontaneous Cerebellar Hemorrhage.

Authors:  Jun Shen; Xuefei Shao; Ruixiang Ge; Guangfu Di; Xiaochun Jiang
Journal:  Risk Manag Healthc Policy       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.